Table 2.
Variable | Overall Cohort |
Study 1 “Specificity” |
Study 2 “Cutoff” |
Study 3 “Deep-C” |
P-value | |
---|---|---|---|---|---|---|
Patients, n | 1050 | 485 | 228 | 337 | ||
Median age (IQR), years |
65.6 (56.8, 72.3) | 64.1 (56.6, 71.8) | 62.4 (53.0, 70.9) | 68.5 (65.0, 73.8) | <0.0001 | |
Women, n (%) | 563 (54) | 257 (53) | 119 (52) | 187 (55) | 0.70 | |
White race, n (%) | 981 (93) | 437 (90) | 216 (95) | 328 (97) | <0.0001 | |
Patient status by specificity cut-off |
||||||
Per-protocol (90%) | ||||||
FP, n (%) | 160(15) | 65 (13) | 36 (16) | 59 (18) | 0.27 | |
TN, n (%) | 890 (85) | 420 (87) | 192 (84) | 278 (82) | ||
Calibrated (90%) | ||||||
FP, n (%) | 113 (11) | 53 (11) | 25 (11) | 35 (10) | 1.00 | |
TN, n (%) | 937 (89) | 432 (89) | 203 (89) | 302 (90) | ||
Calibrated (95%) | ||||||
FP n (%) | 51 (5) | 25 (5) | 10 (4) | 16 (5) | 0.93 | |
TN, n (%) | 999 (95) | 460 (95) | 218 (96) | 321 (95) |
IQR, Interquartile Range; FP, False Positive; TN, True Negative